Nevertheless, and in agreement with reports describing changes in vesicular Zn2+ as well as “elemental zinc” in breast cancer cells, potential Zn2+ release from protein or vesicles may be sufficient for triggering ZnR/GPR39 activation. Here, GPR39 is linked to breast carcinoma.